Levothyroxine Sodium Tablet
Product Images NDC 50090-7767

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 50090-7767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure diagram of levothyroxine sodium showing its molecular components including iodine atoms, hydroxyl group, and sodium salt form with water of hydration.*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

FDA Label Image

Label Image (Lbl500907767)

Label Image (Lbl500907767)
Levothyroxine Sodium USP 0.137 mg oral tablets packaging label from A-S Medication Solutions. The label includes dosage strength .137 mg, storage instructions to keep at 77 degrees Fahrenheit, and a package count of 90 tablets. The labeler is located in Libertyville, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.